TIL
Instil Bio, Inc.
$7.75
+0.03 (+0.39%)
At close · Jul 7
Market Cap
$52.56M
Shares
6,781,976
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.75
Open$7.70
Day$7.67–7.78
52W$5.67–33.83
Avg vol 30d17K
Short int234K · 3.4% float · 17.7d
Short vol24%
Last earningsMay 15, 2026
DataMar 2021–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−28%
below
Price vs 50-day avg
−2%
below
RSI (14)
48
neutral
MACD trend
Positive
52-week position
7%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−4%
trailing
6-month return
+8%
trailing
YTD return
−30%
this year
Relative strength
+1%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $11 — 200d above 50d
Institutional flow
Accumulating
+11% holders QoQ · +10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.45% of float · ▲ +0.4% MoM · 17.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
31 holders — mid 2-yr range
Squeeze score
66
elevated · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
+6%
Y/Y
Free cash flow
$-36.6M
Balance sheet
$6.6M
net cash
Quant / Vol
risk profile
Volatility
84%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
3.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 15, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−28%
Bearish
Price vs 50-day avg
−2%
Neutral
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
7%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $8 › 200d $11 — 200d above 50d
Institutional flow
Accumulating
+11% holders QoQ · +10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.45% of float · ▲ +0.4% MoM · 17.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
31 holders — mid 2-yr range
Price context
position in its 52-week range
52-wk low $6
Now $8 · 7%
52-wk high $34
vs 200-day avg -28%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TIL
this stock
Instil Bio, Inc.
|
$52.56M | -29.5% | — | — | 3.4% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TIL | +2.9% | -4.0% | +8.4% | +0.8% | -29.6% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +2.0% | -5.4% | +0.8% | +0.7% | -39.2% |